NCT04867551View on ClinicalTrials.gov

A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

September 6, 2021

Study Completion Date

September 6, 2021

Conditions
Parkinson Disease
Interventions
DRUG

KDT-3594

oral administration, dose titration

Trial Locations (1)

Unknown

Research Site, Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY